FDA Inspection
L'OREAL USA, INC.L'OREAL USA, INC. – FDA Inspection, Jun 24, 2022
Record Details
This FDA Inspection record concerns L'OREAL USA, INC., with an inspection on June 24, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- L'OREAL USA, INC.
- Inspection Date
- June 24, 2022
- Product Type
- Drugs
View Company Profile
ID · 5115d1e2-2f2c-4160-8869-a8eb6599a6a2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1172731
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.182Personnel dating/signing equipment log
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of L'OREAL USA, INC.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 12, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 30, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 14, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for L'OREAL USA, INC.
- FDA Inspection 989523 - 2016-08-12
- FDA Inspection 805325 - 2012-10-30
- FDA Inspection 634549 - 2009-12-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.